Delivery Order SPE2DR25D2005-SPE2DR26FE7X6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,207.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,784.59 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, issued on October 16, 2025, with completion expected by October 17, 2025, was awarded without set-aside restrictions through competitive procurement. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,656.85 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. This contract, awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, is a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a $21,896.92 delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a prescription medication used to treat autoimmune and inflammatory conditions. The contract, issued as a firm fixed-price delivery order with no set-aside designation, was competitively awarded and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025....
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,591.96 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable pharmaceutical product used to treat autoimmune conditions. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, utilizing firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,411.86 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable pharmaceutical product used for treating inflammatory conditions. This firm fixed-price delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,662.84 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for treating inflammatory conditions. This competitively awarded, firm fixed-price delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used primarily for autoimmune conditions. This firm fixed-price delivery order, valued at $7,754.51, was competitively awarded with no set-aside designation and carries an ultimate completion date of June 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used for treating autoimmune conditions. This competitively awarded, non-set-aside contract carries a ceiling value of $74,738.08 under a firm fixed-price arrangement, with a completion date of August 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription immunosuppressant medication used to treat autoimmune conditions, with a ceiling value of $25,231.50. The contract, issued as a firm fixed-price delivery order on December 4, 2025, with an ultimate completion date of December 5, 2025, was competitively awarded without set-aside provisions. Performance will take place at AmerisourceBergen's...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE7X6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription injectable medication used to treat autoimmune conditions. This firm fixed-price contract, valued at $2,679.72, was competitively awarded without a set-aside designation and is scheduled for completion by December 3, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as both the company's corporate headquarters and a primary distribution point for federal medical procurement. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen leverages this contract framework to fulfill diverse medical supply needs across multiple therapeutic domains for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/1/25 |